The inhibitory effect of glycolic acid and lactic acid on melanin synthesis in melanoma cells

Experimental Dermatology, Supplement

Volumn 12, Issue 2, 2003, Pages 43-50

  Usuki, Akiko ^a   Ohashi, Akiko ^a   Sato, Hirofumi ^a   Ochiai, Y ^a   Ichihashi, Masamitsu ^a   Funasaka, Yoko ^a  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Glycolic acid; Lactic acid; Melanin; Tyrosinase; Hydroxy acid

Indexed keywords

2 HYDROXYACID; DOPACHROME TAUTOMERASE; GLYCOLIC ACID; LACTIC ACID; MELANIN; MESSENGER RNA; MONOPHENOL MONOOXYGENASE; TYROSINASE RELATED PROTEIN 1; TYROSINASE RELATED PROTEIN 2;

ACIDITY; ANIMAL CELL; CANCER GROWTH; CATALYSIS; CELL GROWTH; CHLOASMA; CONFERENCE PAPER; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; ENZYME ACTIVITY; EPIDERMIS; HUMAN; HUMAN CELL; HYPERPIGMENTATION; LENTIGO; MELANOGENESIS; MELANOMA CELL; MOLECULAR SIZE; MOUSE; NONHUMAN; NORTHERN BLOTTING; PH MEASUREMENT; PROTEIN EXPRESSION; PROTEIN SYNTHESIS INHIBITION; QUANTITATIVE ASSAY; SKIN DEFECT; WESTERN BLOTTING;

EID: 0346873979     PISSN: 14791250     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0625.12.s2.7.x     Document Type: Conference Paper

References (48)

1. Mark, G R. Therapeutics: Personal practice The clinical use of alpha hydroxy acids. Australas J Dermatol 1994: 35: 29-33.
2. Cherie M D, Thomas D G, George F M et al. Effects of α-hydroxy acids on photoaged skin: A pilot clinical, histologic, and ultrastructural study. J Am Acad Dermatol 1996: 34: 187-95.
3. Funasaka Y, Sato H, Usuki A et al. The efficacy of glycolic acid for treating wrinkles: Analysis using newly developed facial imaging systems equipped with fluorescent illumination. J Dermatol Sci Suppl 2001: 1: 53-59.
4. Van Scott E J, YuR J. Alpha hydroxy acids: Procedures for use in clinical practice. Cutis 1989: 43: 222-228.
5. Newman N, Newman A, Moy L, Babapour R, Harris A G, Moy R L. Clinical improvement of photoaged skin with 50% glycolic acid. A double-blind vehicle-controlled study. Dermatol Surg 1996: 22: 455-460.
6. Joyce T E L, Siew N T. Glycolic acid peels in the treatment of melasma among Asian women. Dermatol Surg 1997: 23: 177-179.
7. Joyce T E L. Treatment of melasma using kojic acid in a gel containing hydroquinone and glycolic acid. Dermatol Surg 1999: 25: 282-284.
8. Lawerence N, Cox S E, Brody H J. Treatment of melasma with Jessner's solution versus glycolic acid: A comparison of clinical efficacy and evaluation of the predictive ability of Wood's light examination. J Am Acad Dermatol 1997: 36: 589-593.
9. Alicia G, James E F. The combination of glycolic acid and hydroquinone or kojic acid for the treatment of melasma and related conditions. Dermatol Surg 1996: 22: 443-447.
10. Claudia C, Ketty P, Maria T N, Maria C F, Sergio C. The use of chemical peelings in the treatment of different cutaneous hyperpigmentations. Dermatol Surg 1999: 25: 450-454.
11. Lenore S K, Nicholas J L. Azelaic acid and glycolic acid combination therapy for facial hyperpigmentation in darker-skinned patients: A clinical comparison with hydroquinone. Clin Ther 1998; 20: 960-970.
12. Robert L B, Paula L P-B, Monica A L, Todd B L, Duyen T F, David P F. Glycolic acid peels for postinflammatory hyperpigmentation in black patients. Dermatol Surg 1997: 23: 171-175.
13. Walters P S. The effect of topical L (+) lactic acid and ascorbic acid on skin whitening. Int J Cosmet Sci 1999: 21: 33-40.
14. Ando S, Ando O, Suemoto Y, Mishima Y. Tyrosinase gene transcription and its control by melanogenic inhibitors. J Invest Dermatol 1993: 100: 150S-155S.
15. Hearing V J, Tsukamoto K. Enzymatic control of pigmentation in mammals. FASEB J 1991: 5: 2902-2909.
16. Hearing V J. The regulation of melanin formation. The Pigmentary System: Physiology and Pathophysiology. In: Nordlund, J J, ed. 1998: 423-438.
17. Chakraborty A K, Platt J, Kim K K, Kwon B S, Bennett D C, Pawelek J M. Polymerization of 5,6-dihydroxyindole-2-carboxylic acid to melanin by the pmel17/silver locus protein. Eur J Biochem 1996: 236: 180-188.
18. Pawelek J M, Chakraborty A K, Osber M P et al. Molecular cascades in UV-induced melanogenesis: A central role for melanotropins. Pigment Cell Res 1992: 5: 348-356.
19. Ohashi A, Funasaka Y, Ueda M et al. c-KIT receptor expression in cutaneous malignant melanoma and melanocytic naevi. Melanoma Res 1996: 6: 25-30.
20. Oka M, Ichihashi M, Chakraborty A K. Enhanced expression of protein kinase C subspecies during stimulation of melanogenesis in B16 mouse melanoma cells. J Invest Dermatol 1996: 106: 377-378.
21. Kosano H, Setogawa T, Kobayashi K, Nishigori H. Pyrroloquinoline quinone (PQQ) inhibits the expression of tyrosinase mRNA by alpha-melanocyte stimulating hormone in murine B16 melanoma cells. Life Sci 1995: 56: 1707-1713.
22. Hara H, Lee M H, Chen H, Luo D, Jimbow K. Role of gene expression and protein synthesis of tyrosinase, TRP-1, Lamp-1, and CD63 in UVB-induced melano-genesis in human melanomas. J Invest Dermatol 1994: 102: 495-500.
23. Jimenez M, Tsukamoto K, Hearing V J. Tyrosinases from two different loci are expressed by normal and by transformed melanocytes. J Biol Chem 1991; 266: 1147-1156.
24. Tsukamoto K, Jackson I J, Urabe K et al. A second tyrosinase related protein, TRP-2 is a melanogenic enzyme termed DOPAchrome tautomerase. EMBO J 1992: 11: 519-526.
25. Vijayasaradhi S, Bouchard B, Houghton A N. The melanoma antigen gp75 is the human homologue of the mouse b (brown) locus gene product. J Exp Med 1990: 171: 1375-1380.
26. Pawelek J. Melanoma cells in culture. Meth Enzymol 1978: 58: 564-570.
27. Funasaka Y, Chakraborty A K, Komoto M, Ohashi A, Ichihashi M. The depigmenting effect of α-tocopheryl ferulate on human melanoma cells. Br J Dermatol 1999: 141: 20-29.
28. Korner A M, Pawelek J M D O P. Achrome conversion: A possible control point in melanin biosynthesis. J Invest Dermatol 1980: 75: 192-195.
29. Hearing V J. Mammalian monophenol monooxygenase (tyrosinase): Purification, properties, and reactions catalyzed. Meth Enzymol 1987: 142: 154-165.
30. Chakraborty A K, Funasaka Y, Komoto M et al. Effect of arbutin on melanogenic proteins in human melanocytes. Pigment Cell Res 1998: 11: 206-212.
31. Aroca P, Urabe K, Kobayashi T et al. Melanin biosynthesis patterns following hormonal stimulation. J Biol Chem 1993: 268: 25650-25655.
32. Kameyama K, Takemura T, Hamada Y et al. Pigment production in murine melanoma cells is regulated by tyrosinase, tyrosinase-related protein 1 (TRP1), DOPAachrome tautomerase (TRP2), and a melanogenic inhibitor. J Invest Dermatol 1993: 100: 126-131.
33. Martinez-Liarte J H, Solano F, Garcia-Borron J C et al. Alpha-MSH and other melanogenic activators mediate opposite effects on tyrosinase and DOPAchrome tautomerase in B16-F10 mouse melanoma cells. J Invest Dermatol 1992: 99: 435-439.
34. Mengeaud V, Ortonne J P. PUVA (5-methoxypsoralen plus UVA) enhances melanogenesis and modulates expression of melanogenic proteins in cultured melanocytes. J Invest Dermatol 1996: 107: 57-62.
35. Romero C, Aberdam E, Larnler C et al. Retinoic acid as modulator of UVB-induced melanocyte differentiation involvement of the melanogenic enzyme expression. J Cell Sci 1994: 107: 1095-1103.
36. Bouchard B, Del Marmol V, Jackson I et al. Molecular characterization of a human tyrosinase related protein-2 cDNA. Patterns of expression in melanocytic cells. Eur J Biochem 1994: 219: 127-134.
37. Jackson I J A. cDNA encoding tyrosinase-related protein maps to the brown (b) locus in mice. Proc Natl Acad Sci USA 1988; 85: 4392-4396.
38. Jackson I J, Chambers D M, Rinchik E M et al. Characterization of TRP-1 mRNA levels in dominant and recessive mutations at the mouse brown (b) locus. Genetics 1990: 126: 451-459.
39. Jimenez-Cervantes C, Solano F, Kobayashi T et al. A new enzymatic function in the melanogenic pathway. The DHICA oxidase activity of tyrosinase related protein-1 (TRP-1). J Biol Chem 1994: 269: 17993-18001.
40. Kobayashi T, Urabe K, Winder A J et al. Tyrosinase related protein (TRP-1) functions as a DHICA oxidase in melanin biosynthesis. EMBO J 1994: 13: 5818-5825.
41. Zhao H, Zhao Y, Nordlund J J et al. Human TRP-1 has tyrosine hydroxylase activity but no DOPA oxidase activity. Pigment Cell Res 1994: 7: 131-140.
42. Hearing V J. Unraveling the melanocyte. Am J Hum Genet 1993: 52: 1-7.
43. Winder A J, Wittbjer A, Rosengren E et al. The mouse brown (b) locus protein has DOPAchrome tautomerase activity and is located in lysosomes in transfected fibroblasts. J Cell Sci 1993: 106: 153-166.
44. Halaban R, Moellmann G E. Murine and human b locus pigmentation genes encode a glycoprotein (gp75) with catalase activity. Proc Natl Acad Sci USA 1990: 87: 4809-4813.
45. Orlow S J, Zhou B K, Chakraborty A K et al. High molecular weight forms of tyrosinase and the tyrosinase-related proteins: Evidence for a melanogenic complex. J Invest Dermatol 1994: 103: 196-201.
46. Hearing V J, Tsukamoto K, Urabe K et al. Functional properties of cloned melanogenic proteins. Pigment Cell Res 1992: 5: 264-270.
47. Winder A J, Kobayashi T, Tsukamoto K et al. The tyrosinase gene family. Interactions of melanogenic proteins to regulate melanogenesis. Cell Mol Biol Res 1994: 40: 613-626.
48. Zhao H, Eling D J, Medrano E E et al. Retroviral infection with human tyrosinase-related protein-1 (TRP-1) cDNA upregulates tyrosinase activity and melanin synthesis in a TRP-1 deficient melanoma cell line. J Invest Dermatol 1996: 106: 744-752.